MANIPULATION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION REVEALS METASTATIC BREAST CANCERS SUPPORT IMMUNE SUPPRESSION VIA HEME METABOLISM

被引：1
|
作者：
Williams, Michelle [1 ]
Hafeez, Sabrina [1 ]
Christenson, Jessica [1 ]
Spoelstra, Nicole [1 ]
Slansky, Jill [1 ]
Richer, Jennifer [1 ]
机构：
[1] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.890
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
890
引用
收藏
页码：A933 / A933
页数：1
相关论文
共 50 条
  • [1] IMPACT OF REVERSING AN EPITHELIAL-TO-MESENCHYMAL TRANSITION PROGRAM ON TUMOR METABOLISM AND IMMUNE SUPPRESSION
    Williams, Michelle
    Christenson, Jessica
    O'Neill, Kathleen
    Hafeez, Sabrina
    Spoelstra, Nicole
    Slansky, Jill
    Richer, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A440 - A440
  • [2] TUMOR PROFILING REVEALS EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) AND ENHANCED IMMUNE SUPPRESSION IN GLIOSARCOMAS RELATIVE TO GLIOBLASTOMA
    Dardis, Christopher
    Phuphanich, Surasak
    Sanai, Nader
    Xiu, Joanne
    Mittal, Sandeep
    Michelhaugh, Sharon
    Subramaniam, Deepa
    Pandey, Majari
    Kesari, Santosh
    Heimberger, Amy
    Gatalica, Zoran
    Korn, W. Michael
    Sumrall, Ashley
    NEURO-ONCOLOGY, 2018, 20 : 237 - 237
  • [3] Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
    Williams, Michelle M.
    Hafeez, Sabrina A.
    Christenson, Jessica L.
    O'Neill, Kathleen, I
    Hammond, Nia G.
    Richer, Jennifer K.
    PHARMACEUTICALS, 2021, 14 (11)
  • [4] Mitotic kinases as drivers of the epithelial-to-mesenchymal transition and as therapeutic targets against breast cancers
    Colon-Marrero, Stephanie
    Jusino, Shirley
    Rivera-Rivera, Yainyrette
    Saavedra, Harold, I
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (09) : 1036 - 1044
  • [5] Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
    Savci-Heijink, C. D.
    Halfwerk, H.
    Hooijer, G. K. J.
    Koster, J.
    Horlings, H. M.
    Meijer, S. L.
    van de Vijver, M. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 649 - 659
  • [6] Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
    C. D. Savci-Heijink
    H. Halfwerk
    G. K. J. Hooijer
    J. Koster
    H. M. Horlings
    S. L. Meijer
    M. J. van de Vijver
    Breast Cancer Research and Treatment, 2019, 174 : 649 - 659
  • [7] A novel in vivo model of breast cancer hypoxia reveals an epithelial-to-mesenchymal transition switch
    Tiezzi, Daniel G.
    Antonio, Heriton M. R.
    Sicchieri, Renata D.
    Milanezi, Cristiana M.
    Mandarano, Larissa R. M.
    Coelho, Alan A.
    de Andrade, Jurandyr M.
    CANCER RESEARCH, 2013, 73 (08)
  • [8] DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells
    Sung, Nam Ji
    Kim, Na Hui
    Bae, Na Young
    Jo, Hyo Sik
    Park, Sin-Aye
    BIOSCIENCE REPORTS, 2020, 40
  • [9] Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
    Li, Qiu-Hua
    Liu, Zhao-Zhe
    Ge, Ya-Nan
    Liu, Xing
    Xie, Xiao-Dong
    Zheng, Zhen-Dong
    Ma, Yue-Hai
    Liu, Bin
    ONCOLOGY REPORTS, 2020, 44 (02) : 509 - 518
  • [10] Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells
    Cohen, Evan N.
    Gao, Hui
    Anfossi, Simone
    Mego, Michal
    Reddy, Neelima G.
    Debeb, Bisrat
    Giordano, Antonio
    Tin, Sanda
    Wu, Qiong
    Garza, Raul J.
    Cristofanilli, Massimo
    Mani, Sendurai A.
    Croix, Denise A.
    Ueno, Naoto T.
    Woodward, Wendy A.
    Luthra, Raja
    Krishnamurthy, Savitri
    Reuben, James M.
    PLOS ONE, 2015, 10 (07):
12345